[1]刘轶刚,刘博,周密.非动脉瘤性蛛网膜下腔出血的脑脊液外引流术治疗[J].中国临床神经外科杂志,2023,28(05):340-341.[doi:10.13798/j.issn.1009-153X.2023.05.016]
点击复制

非动脉瘤性蛛网膜下腔出血的脑脊液外引流术治疗()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
28
期数:
2023年05期
页码:
340-341
栏目:
经验介绍
出版日期:
2023-05-31

文章信息/Info

文章编号:
1009-153X（2023）05-0340-02
作者:
刘轶刚; 刘博; 周密
471000河南洛阳，联勤保障部队第989医院神经外科（刘轶刚、刘博、周密）
关键词:
非动脉瘤性蛛网膜下腔出血; 脑脊液外引流术; 腰池持续引流术; 疗效
分类号:
B
DOI:
10.13798/j.issn.1009-153X.2023.05.016
文献标志码:
R743;R651.1+1
摘要:
目的 总结非动脉瘤性蛛网膜下腔出血（NASAH）的脑脊液（CSF）外引流术治疗经验。方法 回顾性分析2017年1月至2021年12月接受CSF外引流术治疗的10例NASAH的临床资料。结果 6例为幕前/中脑周围出血，4例为典型的高血压性脑出血；8例进行腰大池置管持续CSF外引流，2例脑室外引流24~48 h后联合腰池持续引流。平均引流时间（9.2±2.86）d。术后症状改善。出院2周复查CT显示出血明显改善，其中5例完全消失。无血管痉挛、颅内感染、迟发性脑积水等并发症。术后随访3个月，10例改良Rankin量表评分均为0分。结论 CSF外引流术尤其是腰大池持续引流可作为NASAH的有效治疗方案，有助于加快症状缓解和早日恢复。

参考文献/References:

[1]Conzen C, Weiss M, Albanna W, et al. Baseline characteristics and outcome for aneurysmal versus non-aneurysmal subarachnoid hemorrhage: a prospective cohort study [J]. Neurosurg Rev, 2022, 45(2): 1413-1420.
[2]Yuan Y, Chen J, Zhang Y, et al. Exploration of risk factors for poor prognosis of non-traumatic non-aneurysmal subarachnoid hemorrhage [J]. Biomolecules, 2022, 12(7): 948-962.
[3]Zinganell A, Bsteh G, Di Pauli F, et al. Longitudinal ventricular cerebrospinal fluid profile in patients with spontaneous subarachnoid hemorrhage [J]. Front Neurol, 2022, 13: 861625.
[4]朱雨峰，杨　鹏，金小青，等. 动脉瘤性蛛网膜下腔出血术后持续脑脊液引流作用的Meta分析[J]. 中华神经外科杂志，2021，37（4）：406-414.
[5]Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage [J]. Lancet, 2017, 389(10069): 655-666.
[6]Páez-Granda D, Parrilla G, Díaz-Pérez J, et al. Are modified Fisher scale and bleeding pattern helpful predictors of neurological complications in non-aneurysmal subarachnoid hemorrhage [J]. Neuroradiology, 2021, 63(2): 253-257.
[7]李宏建. 动脉瘤性与非动脉瘤性蛛网膜下腔出血的基线特征和转归[J]. 国际脑血管病杂志，2021，29（12）：952-952.
[8]Haugh JP, Turkalp Z, Sivam H, et al. Treatment and out-comes of non-aneurysmal perimesencephalic subarachnoid haemorrhage: a 5 year retrospective study in a tertiary care centre [J]. Clin Neurol Neurosurg, 2022, 222: 107448.
[9]Miao YF, Peng T, Moody MR, et al. Delivery of xenon-containing echogenic liposomes inhibits early brain injury following subarachnoid hemorrhage [J]. Sci Rep, 2018, 8(1): 1-12.
[10]Righy C, Turon R, Freitas G, et al. Hemoglobin metabolism by-products are associated with an inflammatory response in patients with hemorrhagic stroke [J]. Rev Bras Ter Intensive, 2018, 30: 21-27.
[11]Garvayo M, Messerer M, Starnoni D, et al. The positive impact of cisternostomy with cisternal drainage on delayed hydrocephalus after aneurysmal subarachnoid hemorrhage [J]. Acta Neurochir (Wien), 2023: 165(1): 187-195.
[12]Capion T, Lilja-Cyron A, Juhler M, et al. Prompt closure versus gradual weaning of extraventricular drainage for hydrocephalus in adult patients with aneurysmal subarachnoid haemorrhage: a systematic review protocol with metaanalysis and trial sequential analysis [J]. BMJ Open, 2019, 9(10): 1-8.
[13]侯春慧. 腰大池引流预防非动脉瘤性蛛网膜下腔出血后DCVS效果观察[J]. 河南医学研究，2018，27（11）：1992-1994.
[14]Xia C, Cheng C, Li D, et al. A new protocol to treat moderate to severe intraventricular hemorrhage with obstructive hydrocephalus [J]. Neurol Res, 2014, 36(11): 955-961.
[15]Kedziora J, Burzynska M, Gozdzik W, et al. Brain-specific biomarkers as mortality predictors after aneurysmal subarachnoid haemorrhage [J]. J Clin Med, 2020, 9(12): 4117-4130.

备注/Memo

备注/Memo:
（2023-01-09收稿，2023-02-09修回）
更新日期/Last Update: 2022-05-31